138. Differential HBV replicative markers and covalently closed circular DNA transcription in immune-active chronic hepatitis B with and without HBeAg
145. The effect of HBV-DNA change on tumor recurrence in resected HBV-HCC patients: A multi-center study
149. Comparison of surgical and long-term outcomes after liver resection in patients with NAFLD-HCC versus HBV-HCC: A multicenter matched analysis
150. Concurrent Usage of Antibiotics with Anti-PD-1 Antibody Associated with Reduced Anti-tumor Efficacy in Advanced Biliary Tract Cancer
151. Do low skeletal muscle mass and disturbed body fat volume have survival impact on stage I/II HCC patients undergoing hepatectomy?
152. Efficacy and safety of donafenib combined with TACE for postoperative adjuvant therapy in patients with high risk of recurrence of hepatocellular carcinoma: a retrospective analysis
153. Efficacy and safety of yttrium-90 transarterial radioembolization for intermediate- and advanced-stage hepatocellular carcinoma
154. Efficacy of Yttrium90 Transarterial Radioembolization as a Bridge to Surgery
155. Fluorescence-guided Laparoscopic Portal Vein Basin Hepatectomy via Indocyanine Green Injected into the Main Portal Vein: A Single-center Experience
156. Health Economics Study of Robots and Laparoscopy liver resecton for Hepatocellular Carcinoma
160. Predictors of micrometastases in patients with Barcelona Clinic Liver Cancer classification B hepatocellular carcinoma
161. Propensity Score-Matched Study on the Benefit of Conversion Therapy in Hepatocellular Carcinoma Treatment
162. Resectability as a Prognostic Indicator in BCLC Stage B Hepatocellular Carcinoma: Challenging Current Treatment Paradigms
165. Short-term Outcomes of Indocyanine Green Fluorescence-guided Anterior Approach for Laparoscopic Right Hemihepatectomy in the Treatment of Hepatocellular Carcinoma
166. Surgical and long-term outcome between Open and minimally invasive liver resection for multiple hepatocellular carcinoma : A propensity-score matched analysis
167. Surgical strategy for incidental intrahepatic cholangiocarcinoma in terms of lymph node dissection
168. Textbook outcomes in initial liver resection for hepatocellular carcinoma: a study with malnutrition graded by the GLIM criteria.
171. Clinical Significance of Hepatectomy for Hepatocellular Carcinoma Associated with Lymph Node and/or Distant Metastases
172. Effects of Neoadjuvant Therapy on Mortality and Hospital Stay after Hepatectomy for Cancer
173. Initial Experience with Single Port Robotic Liver Resection using the da Vinci SP System: A Case Series
174. Laparoscopic Liver Resection after Pancreaticoduodenectomy
175. Liver Transplantation for Far Advanced Hepatocellular Carcinoma with Major Vascular Involvement: A Case
178. Should lymph node dissection be recommended in intrahepatic cholangiocarcinoma patients? A retrospective study from National Cancer Center of China
179. Clinical Outcome of Hepatocellular Carcinoma after Radiofrequency Ablation According to Distance Between Liver Surface and Hilum
180. Combination of SBRT with SIRT: Case Series about the Safety and Efficacy for PHC with PVTT
181. Difference in the development of acute kidney injury by chemotherapeutic agents in patients with hepatocellular carcinoma undergoing transarterial chemoembolization
184. Position of Hepatic Arterial Infusion Chemotherapy in the treatment of HCC
185. Safety of Radiofrequency Ablation for Hepatocellular Carcinoma in Patients after Endoscopic Papillary Balloon Dilation
186. The Efficacy and Safety of Selective Internal Radiation Therapy in Large Unresectable Hepatocellular Carcinoma: the First Experience in Chinese Patients
188. Transarterial Radioembolization versus Atezolizumab plus Bevacizumab in Treatment-naïve Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombosis
189. Unveiling Real-World Insights on the Vital Role of Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma Patients